Q/C Technologies, Inc

QCLSNASDAQ · In Vitro & in Vivo Diagnostic Substances

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

8.19M

on 2026-06-30, from 22K on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-98 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

$100.0M

S-3 of 2026-02-11. None sold under it to 2026-10-05. S-3 ↗

10 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-12 is not read yet.

Cash

4.6 quarters

$11.0M on 2026-06-30 ÷ $2.4M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2025-09-02	Private placement	7,000	not read	$7.0M	8-K ↗

Also on file: a 1-for-2 reverse split, 2025-01-01 8-K ↗ · a 1-for-100 reverse split, 2025-09-01 8-K ↗